John Anthony Hardy British geneticist (b. 1954)
Hardy, John A.
Hardy, John, 1954-
Hardy, John
Hardy, John E. R.
VIAF ID: 9285947 (Personal)
Permalink: http://viaf.org/viaf/9285947
Preferred Forms
- 100 1 _ ‡a Hardy, John
-
- 100 1 _ ‡a Hardy, John A.
- 100 1 _ ‡a Hardy, John E. R.
-
- 100 1 _ ‡a Hardy, John, ‡d 1954-
-
- 100 0 _ ‡a John Anthony Hardy ‡c British geneticist (b. 1954)
4xx's: Alternate Name Forms (19)
Works
Title | Sources |
---|---|
Animated tales of the world | |
Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines | |
Cooperative genome-wide analysis shows increased homozygosity in early onset Parkinson's disease | |
Correction: Alzheimer's disease polygenic risk score as a predictor of conversion from mild-cognitive impairment. | |
Correction: Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies. | |
Correction to: Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer's disease resilience. | |
Correlation of proband and sibling stroke latency: the SWISS Study. | |
Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates. | |
Corrigendum to "Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy." [Neurobiol. Aging 35 (2014) 1514.e1-1514.e12]. | |
Corticobasal Degeneration and Frontotemporal Dementia Presentations in a Kindred with Nonspecific Histopathology | |
CR1 is associated with amyloid plaque burden and age-related cognitive decline | |
Creation of an open-access, mutation-defined fibroblast resource for neurological disease research | |
Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. | |
Cross-platform transcriptional profiling identifies common and distinct molecular pathologies in Lewy body diseases | |
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4. | |
D21S194, a jump clone from D21S16. | |
Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans | |
Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data | |
Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls | |
Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT | |
Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study | |
Differential DJ-1 gene expression in Parkinson's disease. | |
Differential Transmitter Release from Nerve Terminals Isolated from Basal Ganglia and Substantia Nigra | |
Disentangling the role of the tau gene locus in sporadic tauopathies | |
Disintegrating brain networks: from syndromes to molecular nexopathies | |
Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. | |
Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation | |
Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. | |
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers | |
Does APOE explain the linkage of Alzheimer's disease to chromosome 19q13? | |
Does the difference between PART and Alzheimer's disease lie in the age-related changes in cerebral arteries that trigger the accumulation of Aβ and propagation of tau? | |
Dopamine and apomorphine do not modulate the uptake of [3H]D-aspartate in the rat striatum in-vitro. | |
Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series | |
DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA | |
DYT6 Dystonia: A Neuropathological Study. | |
Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene | |
Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations | |
Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation | |
Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials | |
Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study | |
Egiptomanía : el fascinante mundo del antiguo Egipto = Egyptomania | |
Egyptomania (Planeta-DeAgustini) | |
Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease | |
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease | |
Epigenetic mechanisms in Alzheimer's disease: progress but much to do. | |
Erratum: correction: Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease | |
Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease | |
Erratum to: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay | |
Erratum to "Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome" [Neurobiol. Aging 35 (2014) 1513.e1-1513.e5]. | |
Establishing the role of rare coding variants in known Parkinson's disease risk loci | |
European voyaging towards Australia : [papers presented at an international colloquium held at the Chateau d'Entrecasteaux, 1987] | |
A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder | |
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk | |
An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of α-synuclein | |
An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease | |
Jane Austen's heroines : Intimacy in human relationships | |
L'Egypt | |
Merlí i els dracs un conte del País de Gal·les | |
Neurodegeneration, 2005: | |
A new presenilin Alzheimer's disease case confirms the helical alignment of pathogenic mutations in transmembrane domain 5. | |
A novel A781V mutation in the CSF1R gene causes hereditary diffuse leucoencephalopathy with axonal spheroids | |
A novel Alzheimer disease locus located near the gene encoding tau protein. | |
De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions | |
A paired RNAi and RabGAP overexpression screen identifies Rab11 as a regulator of β-amyloid production | |
A phenotype of atypical apraxia of speech in a family carrying SQSTM1 mutation | |
A polymorphic microsatellite repeat sequence on chromosome 21 (D21S80). | |
A presenilin 1 mutation associated with familial frontotemporal dementia inhibits gamma-secretase cleavage of APP and notch. | |
A presenilin 1 mutation (L420R) in a family with early onset Alzheimer disease, seizures and cotton wool plaques, but not spastic paraparesis. | |
Rancid aluminium | |
A rapid method for preparing synaptosomes: comparison, with alternative procedures. | |
A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease | |
Studies from Terra Australis to Australia | |
A survey of genetic human cortical gene expression | |
A thorough assessment of benign genetic variability in GRN and MAPT. | |
Zespoły neurozwyrodnieniowe spowodowane gromadzeniem się żelaza w mózgu - aktualne dane dotyczące objawów klinicznych, podstaw histologicznych i genetycznych oraz możliwości leczenia = Syndromes of Neurodegeneration with Brain Iron Accumulation (NBIA) |